Chk1 Inhibition Ameliorates Alzheimer's Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling.
Hu W, Wang Z, Zhang H, Mahaman YAR, Huang F, Meng D, Zhou Y, Wang S, Jiang N, Xiong J, Westermarck J, Lu Y, Wang J, Wang X, Shentu Y, Liu R.
Hu W, et al. Among authors: mahaman yar.
Neurotherapeutics. 2022 Mar;19(2):570-591. doi: 10.1007/s13311-022-01204-z. Epub 2022 Mar 14.
Neurotherapeutics. 2022.
PMID: 35286657
Free PMC article.